Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2003Current Pharmaceutical Design

Hypertension and Angiogenesis

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

FKFlorian W. KieferBrigham and Women's HospitalSNShiva NeysariRoche (Switzerland)RHRok HumarUniversity of Zurich

Discussion

Loading...

Member takes

Overview

Should not yet change practice; hypothesis-generating for angiogenesis as a therapeutic target in hypertension complications.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kiefer et al. (2003) studied this question.

synapsesocial.com/papers/6a70637ee5469ee92be11fedhttps://doi.org/10.2174/1381612033454540
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nitric Oxide and Angiogenesis in Cardiovascular Disease2002 · 66 citations
  2. 2Lack Of Impairment Of Nitric Oxide-Mediated Responses In A Rat Model Of High-Renin Hypertension2002 · 5 citations
  3. 3Mechanism of hypertension and proteinuria during angiogenesis inhibition2012 · 62 citations
  4. 4Clinical Significance of Nitric Oxide in Hypertension1994 · 5 citations
  5. 5Does the Renin-Angiotensin System Participate in Regulation of Human Vasculogenesis and Angiogenesis?2008 · 92 citations